Experimental Hematology
Volume 38, Issue 4 , Pages 301-310.e2, April 2010

Hypoxia mediates low cell-cycle activity and increases the proportion of long-term–reconstituting hematopoietic stem cells during in vitro culture

  • Pernilla Eliasson

      Affiliations

    • Experimental Hematology Unit, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden
    • Corresponding Author InformationOffprint requests to: Pernilla Eliasson, Ph.D., Experimental Hematology Unit, Department of Clinical and Experimental Medicine, Linköping University, SE-581 85 Linköping, Sweden
  • ,
  • Matilda Rehn

      Affiliations

    • Lund Strategic Center for Stem Cell Biology and Cell Therapy, Lund University, Lund, Sweden
  • ,
  • Petter Hammar

      Affiliations

    • Experimental Hematology Unit, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden
  • ,
  • Peter Larsson

      Affiliations

    • Radiation Physics, Department of Medical and Health Sciences, Faculty of Health Sciences, Linköping University, Linköping, Sweden
  • ,
  • Oksana Sirenko

      Affiliations

    • FibroGen Inc., San Francisco, Calif., USA
  • ,
  • Lee A. Flippin

      Affiliations

    • FibroGen Inc., San Francisco, Calif., USA
  • ,
  • Jörg Cammenga

      Affiliations

    • Lund Strategic Center for Stem Cell Biology and Cell Therapy, Lund University, Lund, Sweden
  • ,
  • Jan-Ingvar Jönsson

      Affiliations

    • Experimental Hematology Unit, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden

Received 14 July 2009; received in revised form 12 January 2010; accepted 22 January 2010. published online 04 February 2010.

Objective

Recent evidence suggests that hematopoietic stem cells (HSCs) in the bone marrow (BM) are located in areas where the environment is hypoxic. Although previous studies have demonstrated positive effects by hypoxia, its role in HSC maintenance has not been fully elucidated, neither has the molecular mechanisms been delineated. Here, we have investigated the consequence of in vitro incubation of HSCs in hypoxia prior to transplantation and analyzed the role of hypoxia-inducible factor (HIF)−1α.

Materials and Methods

HSC and progenitor populations isolated from mouse BM were cultured in 20% or 1% O2, and analyzed for effects on cell cycle, expression of cyclin-dependent kinase inhibitors genes, and reconstituting ability to lethally irradiated mice. The involvement of HIF-1α was studied using methods of protein stabilization and gene silencing.

Results

When long-term FLT3CD34 LinSca-1+c-Kit+ (LSK) cells were cultured in hypoxia, cell numbers were significantly reduced in comparison to normoxia. This was due to a decrease in proliferation and more cells accumulating in G0. Moreover, the proportion of HSCs with long-term engraftment potential was increased. Whereas expression of the cyclin-dependent kinase inhibitor genes p21cip1, p27Kip1, and p57Kip2 increased in LSK cells by hypoxia, only p21cip1 was upregulated in FLT3CD34LSK cells. We could demonstrate that expression of p27Kip1 and p57Kip2 was dependent of HIF-1α. Surprisingly, overexpression of constitutively active HIF-1α or treatment with the HIF stabilizer agent FG-4497 led to a reduction in HSC reconstituting ability.

Conclusions

Our results imply that hypoxia, in part via HIF-1α, maintains HSCs by decreasing proliferation and favoring quiescence.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0301-472X(10)00013-5

doi:10.1016/j.exphem.2010.01.005

Experimental Hematology
Volume 38, Issue 4 , Pages 301-310.e2, April 2010